Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.

Feb 7, 2025 · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

Jan 13, 2025 · Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, genomics AI development, and drug discovery.

Apr 3, 2023 · Illumina, a global leader in DNA sequencing and array-based technologies, celebrates its 25th year in business. For our anniversary, we’re counting the ways our technology has changed health care and the environment

View a complete list of Illumina sequencing and microarray products. Filter by system compatibility and other key features to narrow the list.

Oct 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance …

Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.